OCUL - Ocular Therapeutix - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

874M

Cash

482.9M

Avg Qtr Burn

-21.04M

Short % of Float

16.16%

Insider Ownership

0.78%

Institutional Own.

81.24%

Qtr Updated

03/31/24

Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
DEXTENZA® (dexamethasone ophthalmic insert) Details Eye disease , Allergic conjunctivitis	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ReSure® Sealant Details Intraoperative management of clear corneal incision	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
DEXTENZA® (dexamethasone ophthalmic insert) Details Inflammation and pain following ophthalmic surgery	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
AXPAXLI (OTX-TKI) (axitinib intravitreal implant) Details Wet age-related macular degeneration	Phase 3 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
OTX-CSI (cyclosporine intracanalicular insert) Details Dry eye disease	Phase 2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
OTX-DED (dexamethasone intracanalicular insert) Details Dry eye disease	Phase 2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
PAXTRAVA™ (OTX-TIC) (travoprost implant) Details Ocular hypertension, Primary open angle glaucoma	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
AXPAXLI (OTX-TKI) (axitinib intravitreal implant) Details Eye disease , Diabetic retinopathy	Phase 1 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.